How one California-based CCO is responding to coronavirus risk


We recently spoke with the compliance chief for California-based biopharmaceutical Aimmune, Fabiana Lacerca-Allen, about her role in helping her company proactively plan for and respond to the risks posed by COVID-19.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.